News

MicroRNA-33a and microRNA-33b are encoded within the mammalian SREBF1 and SRBF2 genes, respectively, and both SREBF1 and ...
Researchers identified a combination of two existing cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s ...
Small molecule drugs are low-molecular-weight, organic compounds used to treat a wide range of conditions. Here's what you should know.
Colon cancer is often driven by cancer stem cells, which resist treatment and lead to relapse. In a recent study, researchers ...
In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...
Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...
Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.
From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ ...
Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease ...
PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced the publication of a ...
Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...